Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 Study
...
(vi) Nutrition Recommendations and Interventions for Diabetes: a position statement of the American Diabetes Association. Diabetes Care . 2008;31
suppl 1:S61-78.
(vii) Anderson JW, Kendall CW, Jenkins DJ. Importance of weight management in type 2 diabetes: review with meta-analysis of clinical st...
Meta-Analysis of Clinical Data Showed No Increased Risk of Cardiovascular Events Associated With Exenatide Use: Data Presented at ADA 2009
...7.
(vi) Nutrition Recommendations and Interventions for Diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2008;31
suppl 1:S61-78.
(vii) Anderson JW, Kendall CW, Jenkins DJ. Importance of weight management in type 2 diabetes: review with meta-analysis of clinical stud...
Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years: DURATION-1 Interim Long-Term Data Presented at ADA 2009
...
(vi) Nutrition Recommendations and Interventions for Diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2008;31
suppl 1:S61-78.
(vii) Anderson JW, Kendall CW, Jenkins DJ. Importance of weight management in type 2 diabetes: review with meta-analysis of clinical s...
Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
...
(vi) Nutrition Recommendations and Interventions for Diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2008;31
suppl 1:S61-78.
(vii) Anderson JW, Kendall CW, Jenkins DJ. Importance of weight management in type 2 diabetes: review with meta-analysis of clinical s...
Exenatide Once Weekly Provided Superior Glucose Control With Weight Loss Compared to Sitagliptin or Pioglitazone in Head-to-Head DURATION-2 Study
...
(vi) Nutrition Recommendations and Interventions for Diabetes: a position statement of the American Diabetes Association. Diabetes Care . 2008;31
suppl 1:S61-78.
(vii) Anderson JW, Kendall CW, Jenkins DJ. Importance of weight management in type 2 diabetes: review with meta-analysis of clinical stud...
Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008
.../www.cdc.gov/hepatitis/HCV/HCVfaq.htm#section1 .
(5) Risk factors for hepatitis C recurrence after liver
transplantation. J Viral Hepat. 2007 Nov;14
suppl 1:89-96. Roche B, Samuel
D. Assistance Publique-Hopitaux de Paris, Hopital Paul Brousse, Centre
Hepato-Biliaire; and INSERM, Unite 785; and Universite...
n-3 PUFAs Reduce Mortality and Hospital Admissions in Patients With Symptomatic Heart Failure
... patients with recent myocardial infarction:
insights from the GISSI-Prevenzione trial. Journal of Cardiovascular
Medicine (Hagerstown, MD) 2007 Sep;8
suppl 1:S34-7.
3. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto
Miocardico. Dietary supplementation with n-3 polyunsaturated fatty acids
...
Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel
... platelet blockers?
Circulation. 2001;104(23):2759-2761.
(5) Sobel BE. Optimizing cardiovascular outcomes in diabetes mellitus.
Am J Med. 2007;120(9
suppl 2):S3-11.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061120/DSLLOGO )
...
M. D. Anderson to Initiate Clinical Validation Study on Rosetta Genomics' MicroRNA-based Diagnostic Assay Identifying the Origin of Cancer Metastases
...mary of the Standards, Options and
Recommendations for the management of patients with carcinoma of unknown
primary site (2002). Br J Cancer, 2003. 89
suppl 1: p. S59-66.
Contact: Media & Investors Ron Kamienchick T: +1-646-509-1893 E: investors@rosettagenomics.com
...
After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008
...-47.
(6) Nutrition Recommendations and Interventions for Diabetes: a
position statement of the American Diabetes Association. Diabetes Care.
2007;30
suppl 1:S48-65.
(7) Anderson JW, Kendall CW, Jenkins DJ. Importance of weight
management in type 2 diabetes: review with meta-analysis of clinical
studies...
New Drug Application for Exenatide Once Weekly Accepted for Review by FDA
...
(vi) Nutrition Recommendations and Interventions for Diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2008;31
suppl 1:S61-78.
(vii) Anderson JW, Kendall CW, Jenkins DJ. Importance of weight management in type 2 diabetes: review with meta-analysis of clinical s...
Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes
...
(vi) Nutrition Recommendations and Interventions for Diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2008;31
suppl 1:S61-78.
(vii) Anderson JW, Kendall CW, Jenkins DJ. Importance of weight management in type 2 diabetes: review with meta-analysis of clinical s...
Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events
...
(vi) Nutrition Recommendations and Interventions for Diabetes: a position statement of the American Diabetes Association. Diabetes Care . 2007;30
suppl 1:S48-65.
(vii) Anderson JW, Kendall CW, Jenkins DJ. Importance of weight management in type 2 diabetes: review with meta-analysis of clinical stud...
AdvanDx Receives FDA 510(k) Clearance for E. coli/P. aeruginosa PNA FISH(R)
... Feb;49(2):760-6.
Paterson et al. Clin Infect Dis. 2008 Sep 15;47
suppl 1:S14-20.
Slama et al. Crit Care. 2008;12
suppl 4:S4.
Thom et al. BMC Infect Dis. 2008 Sep 15;8:116.
...
YM BIOSCIENCES RECEIVES CLEARANCE TO INITIATE RANDOMIZED DOUBLE-BLIND CLINICAL TRIALS OF NIMOTUZUMAB IN LUNG CANCER AND BRAIN METASTASES FROM LUNG CANCER
...evels. The Canadian cohort had a median survival of 13.8 months, which compares very favorably with historical data (Brundage Can J Oncol. 1996 Feb; 6
suppl 1:25-32.; Bezjak Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):719-28; Sundstrom J Clin Oncol. 2004 Mar 1;22(5):801-10).
"Numerous NSCLC patients u...
Screening for β2-adrenergic receptor agonists using the pH-sensitive dye,CypHer5, and the IN Cell Analyzer 3000
... dye, CypHer5, and IN Cell Analyzer 3000,
Amersham Biosciences, 18-1177-91, Edition AA (2003).
3. Pouleur et al. Clin. Cardiol., 18 (3
suppl I), 117–21 (1995).
4. Pittaluga and Raiteri. J. Pharmacol. Exp. Ther,. 260 (1), 232–7 (1992).
5. Oakley RH et al. Journal ...
More>>